Evidence map›Paper›PMID 29958546›Full record

ArticleActa neuropathologica communications2018

Neuroimaging-pathological correlations of [

Aiko Ishiki, Ryuichi Harada, Hideaki Kai, Naomi Sato, Tomoko Totsune, Naoki Tomita, Shoichi Watanuki, Kotaro Hiraoka, Yoichi Ishikawa, Yoshihito Funaki and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Yonsei medical journal · 2022
    Trial
  5. Review
  6. Review
  7. Article
  8. Clinical application of MAO-B PET usingGeriatrics & gerontology international · 2024
    Review
  9. Pathomechanisms of depression in progressive supranuclear palsy.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Review
  10. High sensitivity of asymmetricScientific reports · 2023
    Article
  11. Article
  12. Review
  13. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Observational
  14. Journal of neurology · 2022
    Article
  15. Imaging pathological tau in atypical parkinsonisms: A review.Clinical parkinsonism & related disorders · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Aiko IshikiDepartment of Geriatrics and Gerontology, Division of Brain Science, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Ryuichi HaradaDepartment of Geriatrics and Gerontology, Division of Brain Science, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan. ryuichi.harada.c8@tohoku.ac.jp.ORCID 0000-0001-8538-8814
Hideaki KaiDepartment of Neurological Science, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Naomi SatoDepartment of Pathology, Tohoku University School of Medicine, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Tomoko TotsuneDepartment of Nuclear Medicine and Radiology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Naoki TomitaDepartment of Geriatrics and Gerontology, Division of Brain Science, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Shoichi WatanukiCyclotron and Radioisotope Center, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, Japan.
Kotaro HiraokaCyclotron and Radioisotope Center, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, Japan.
Yoichi IshikawaCyclotron and Radioisotope Center, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, Japan.
Yoshihito FunakiCyclotron and Radioisotope Center, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, Japan.
Ren IwataCyclotron and Radioisotope Center, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, Japan.
Shozo FurumotoCyclotron and Radioisotope Center, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, Japan.
Manabu TashiroCyclotron and Radioisotope Center, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, Japan.
Hironobu SasanoDepartment of Pathology, Tohoku University School of Medicine, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Tetsuyuki KitamotoDepartment of Neurological Science, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Yukitsuka KudoDepartment of Geriatrics and Gerontology, Division of Brain Science, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Kazuhiko YanaiDepartment of Pharmacology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Katsutoshi FurukawaDivision of Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-ku, Sendai, Miyagi, Japan.
Nobuyuki OkamuraDepartment of Pharmacology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Hiroyuki AraiDepartment of Geriatrics and Gerontology, Division of Brain Science, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Tohoku University · JPTohoku Institute of Technology · JPTohoku Medical and Pharmaceutical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent positron emission tomography (PET) studies have demonstrated the accumulation of tau PET tracer in the affected region of progressive supranuclear palsy (PSP) cases. To confirm the binding target of radiotracer in PSP, we performed an imaging-pathology correlation study in two autopsy-confirmed PSP patients who underwent [

Indexed as

Positron-Emission TomographyAgedAged, 80 and overAminopyridinesAniline CompoundsAstrocytesAutopsyAutoradiographyCorrelation of DataFemaleGlobus PallidusHumansMagnetic Resonance ImagingMaleMesencephalonMonoamine Oxidase2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAminopyridinesAniline CompoundslazabemideMonoamine OxidaseMonoamine Oxidase InhibitorsNerve Tissue ProteinsPicolinic AcidsQuinolinestau ProteinsThiazolesTHK5351[18F]THK5351Monoamine oxidasePETPSPReactive astrocyteTau

Identifiers

PMID29958546
PMCPMC6025736
OpenAlexW2809949958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.